Terumo Consent Decree Halts Sales Of Firm’s Michigan-Made Heart Devices
This article was originally published in The Gray Sheet
Executive Summary
Terumo Cardiovascular Systems will halt production and sales of two heart-lung bypass systems and other cardiovascular devices manufactured at its Ann Arbor, Mich., facility under an FDA consent decree announced March 22.